Evidence map›Paper›PMID 26202614›Full record

ArticlePsychopharmacology2015

Atomoxetine accelerates attentional set shifting without affecting learning rate in the rat.

Nelson K Totah, Nikos K Logothetis, Oxana Eschenko

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Aberrant Medial Prefrontal Cortex Activity and Flexible Behavior in the TgF344-AD Rat Model of Alzheimer's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nelson K TotahDepartment of Physiology of Cognitive Processes, Max Planck Institute for Biological Cybernetics, Spemannstr. 38, 72076, Tuebingen, Germany, nelson.totah@tuebingen.mpg.de.
Nikos K Logothetis
Oxana Eschenko
Max Planck Institute for Biological Cybernetics · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleShifting to a new rule is a form of behavioral flexibility that is impaired in numerous psychiatric and neurological illnesses. Animal studies have revealed that this form of flexibility depends upon norepinephrine (NE) neurotransmission. Atomoxetine, a NE reuptake inhibitor, improves performance of humans in set shifting tasks.

objectiveOur objective was to validate its effects in a rodent set shifting task.

methodsWe tested the drug effect using an operant task that required a shift from a visual cue-guided behavior to a novel location-guided rule.

resultsA 1.0-mg/kg dose significantly accelerated rule shifting without affecting learning strategies, such as win-stay or lose-shift. Fitting behavioral performance with a learning function provided a measure of learning rate.

conclusionThis novel analysis revealed that atomoxetine accelerated shifting to the new rule without affecting learning rate.

Indexed as

Adrenergic Uptake InhibitorsAnimalsAtomoxetine HydrochlorideAttentionLearningMaleNorepinephrineRatsRats, Sprague-DawleyReaction TimeTime FactorsAdrenergic Uptake InhibitorsAtomoxetine HydrochlorideNorepinephrine

Identifiers

PMID26202614
OpenAlexW1000404704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.